INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07RJRubinstein Julie0B / 37S37 trades$6.38M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$18K
4,000 sh
May 13, 2026May 14, 2026
Page 816 of 1737
← PrevNext →
traded May 13, 2026
+1d
SEC Form 4

Evidence

13
SC
Skinner Todd C.President, International
TRUTransUnion
Grant or award
A—
24.7K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC Form 4

Evidence

13
BS
Buggy ShannonSee Remarks
CRONCronos Group Inc.
Option exercise
M—
20.6K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC Form 4

Evidence

13
CJ
Canino Vincent J.Director, President & CEO
CGEHCapstone Energy Plus, Inc.
Grant or award
A—
65.0K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC Form 4

Evidence

13
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$38K
165 sh
May 1, 2026May 14, 2026
traded May 1, 2026
+13dSEC Form 4

Evidence

12
PT
Page TylerDirector, Chief Executive Officer
CIFRCipher Digital Inc.
Gift
G—
400.0K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC Form 4

Evidence

12
TJ
Tobolski Matthew JosephDirector, Chief Executive Officer
AAONAAON, INC.
Tax withholding
F$63K
467 sh
May 13, 2026May 14, 2026
traded May 13, 2026
+1dSEC Form 4

Evidence

12
BV
Brifo VictoriaDirector
TSETrinseo PLC
Other acquisition or disposition
J—
42.5K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC Form 4

Evidence

11
AC
Ames Sophie CExec. Vice President & CHRO
QBTSD-Wave Quantum Inc.
Tax withholding
F$533K
23.9K sh
May 13, 2026May 14, 2026
traded May 13, 2026
+1dSEC Form 4

Evidence

9
SN
Stillwell Richard NewcombDirector
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
22.7K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC Form 4

Evidence

9
JA
Jackson Stephon A.Vice President
TROWPRICE T ROWE GROUP INC
Grant or award
A$17K
175 sh
May 13, 2026May 14, 2026
traded May 13, 2026
+1dSEC Form 4

Evidence

9
DD
Dodd Alexander DEVP & CFO
AUBAtlantic Union Bankshares Corp
Grant or award
A—
16.4K sh
May 13, 2026May 14, 2026
traded May 13, 2026
+1dSEC Form 4

Evidence

9
FR
Fleck Penny ReneeCHIEF DEVELOPMENT OFFICER
MGTXMeiraGTx Holdings plc
Grant or award
A—
100.0K sh
May 13, 2026May 14, 2026
traded May 13, 2026
+1dSEC Form 4

Evidence

9
YG
York GwillDirector
ANROAlto Neuroscience, Inc.
Grant or award
A—
11.0K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC Form 4

Evidence

9
BB
Burger BasDirector
AKAMAKAMAI TECHNOLOGIES INC
Option exercise
M—
3,028 sh
May 14, 2026May 14, 2026
traded May 14, 2026
+0dSEC Form 4

Evidence

9
MJ
Moore JocelynDirector
DKNGDraftKings Inc.
Option exercise
M—
5,562 sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC Form 4

Evidence

9
SD
Smith Eugene DuboisDirector
MHOM/I HOMES, INC.
Grant or award
A—
1,573 sh
May 13, 2026May 14, 2026
traded May 13, 2026
+1dSEC Form 4

Evidence

9
GL
Grange David LDirector
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
22.7K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC Form 4

Evidence

9
EG
Etess Mitchell G.Director
CNTYCENTURY CASINOS INC /CO/
Grant or award
A—
457 sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC Form 4

Evidence

9
BB
Burger BasDirector
AKAMAKAMAI TECHNOLOGIES INC
Option exercise
M—
3,028 sh
May 14, 2026May 14, 2026
traded May 14, 2026
+0dSEC Form 4

Evidence

9
NS
Nichols Benjamin S.Chief Commercial Officer
CMPCOMPASS MINERALS INTERNATIONAL INC
Tax withholding
F$7,462
247 sh
May 13, 2026May 14, 2026
traded May 13, 2026
+1dSEC Form 4

Evidence

9
BH
Bagger Richard HDirector
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
22.7K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC Form 4

Evidence

9
DB
Doorenbos BobbiDirector
KTOSKRATOS DEFENSE & SECURITY SOLUTIONS, INC.
Grant or award
A—
10.0K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC Form 4

Evidence

9
HR
Hunter James Randolph JrDirector
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
22.7K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC Form 4

Evidence

9
RA
Rajkovic AleksandarDirector
BNGOBionano Genomics, Inc.
Grant or award
A—
9,149 sh
May 14, 2026May 14, 2026
traded May 14, 2026
+0dSEC Form 4

Evidence

9
BS
Bell Margaret SmithDirector
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
22.7K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC Form 4

Evidence

9
CN
Cox Christopher NixonDirector
ANROAlto Neuroscience, Inc.
Grant or award
A—
11.0K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC Form 4

Evidence

9
MH
Manji HusseiniDirector
ANROAlto Neuroscience, Inc.
Grant or award
A—
11.0K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC Form 4

Evidence

9
HA
Hoffman AlisonPresident of Starz Networks
STRZSTARZ ENTERTAINMENT CORP /CN/
Option exercise
M—
13.7K sh
May 14, 2026May 14, 2026
traded May 14, 2026
+0dSEC Form 4

Evidence

9
SR
Sanchez RamiroDirector
ANROAlto Neuroscience, Inc.
Grant or award
A—
11.0K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC Form 4

Evidence

9
BL
Boyd Bradley LDirector
KTOSKRATOS DEFENSE & SECURITY SOLUTIONS, INC.
Option exercise
M—
10.0K sh
May 14, 2026May 14, 2026
traded May 14, 2026
+0dSEC Form 4

Evidence

9
DJ
Doucet Terrence Gregory JosephSee Remarks
CRONCronos Group Inc.
Tax withholding
F$19K
5,199 sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC Form 4

Evidence

9
SB
Stone BenjaminChief Business Officer
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
26.7K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC Form 4

Evidence

9
SB
Stone BenjaminChief Business Officer
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
72.3K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC Form 4

Evidence

9
TA
Tamboli AjimChief Financial Officer
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
13.6K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC Form 4

Evidence

9
BL
Boylston LukeController
NEXTNextDecade Corp
Tax withholding
F$11K
1,312 sh
May 13, 2026May 14, 2026
traded May 13, 2026
+1dSEC Form 4

Evidence

9
TJ
Treco JamesDirector
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
22.7K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC Form 4

Evidence

9
OY
Olukotun Adeoye YDirector
TNXPTonix Pharmaceuticals Holding Corp.
Grant or award
A—
22.7K sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC Form 4

Evidence

9
LC
Levene CatherineDirector
PBIPITNEY BOWES INC /DE/
Grant or award
A—
6,532 sh
May 12, 2026May 14, 2026
traded May 12, 2026
+2dSEC Form 4

Evidence

9
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$352K
1,575 sh
May 13, 2026May 14, 2026
traded May 13, 2026
+1dSEC Form 4

Evidence